1. Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay JP, Thrasher AJ, Wulffraat N, Sorensen R, Dupuis-Girod S, Fischer A, Davies EG, Kuis W, Leiva L, Cavazzana-Calvo M. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002; 346:1185-1193.

2. Sandmair AM, Loimas S, Puranen P, Immonen A, Kossila M, Puranen M, Hurskainen H, Tyynela K, Turunen M, Vanninen R, Lehtolainen P, Paljarvi L, Johansson R, Vapalahti M, Yla-Herttuala S. Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adeno-viruses. Hum Gene Ther 2000; 11:2197-2205.

3. Somia N, Verma IM. Gene therapy: Trials and tribulations. Nat Rev Genet 2000; 1:91-99.

4. O'Reilly DR, Miller LK, Luckov VA. Baculovirus Expression Vectors. A Laboratory Manual. New York: Oxford University Press, 1994.

5. Airenne KJ, Hiltunen MO, Turunen MP, Turunen AM, Laiti-nen OH, KulomaaMS, Ylä-Herttuala S. Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery. Gene Ther 2000; 7:1499-1504.

6. Kost TA, Condreay JP. Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends Biotechnol 2002; 20:173-180.

7. Ghosh S, Parvez MK, Banerjee K, Sarin SK, Hasnain SE. Baculovirus as mammalian cell expression vector for gene therapy: An emerging strategy. Mol Ther 2002; 6:5-11.

8. Miller LK. The Baculoviruses. 1st ed.. New York: Plenum Press, 1997.

9. Black BC, Brennan LA, Dierks PM, Gard IE. Commercialization of baculoviral insecticides. In: Miller LK, Ed. The Bacu-loviruses. New York: Plenum Press, 1997:341-387.

10. Burges HD, Croizier G, Huger J. A review of safety tests on baculoviruses. Entomaphaga 1980; 25:329-340.

11. Granados RR. Replication phenomena of insect viruses in vivo and in vitro. In: Miltenburger HG, Ed. Safety Aspects of Baculoviruses as Biological Insecticides. Bonn: Bundesministerium fur Forschung und Technologie, 1978:163-184.

12. Volkman LE, Goldsmith PA. In vitro survey of Autographa californica nuclear polyhedrosis virus interaction with nontarget vertebrate host cells. Appl Environ Microbiol 1983; 45: 1085-1093.

13. Carbonell LF, Klowden MJ, Miller LK. Baculovirus-mediated expression of bacterial genes in dipteran and mammalian cells. J Virol 1985; 56:153-160.

14. Hofmann C, Sandig V, Jennings G, Rudolph M, Schlag P, Strauss M. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci USA 1995; 92: 10099-10103.

15. Carbonell LF, Miller LK. Baculovirus interaction with nontarget organisms: A virus-borne reporter gene is not expressed in two cell lines. Appl Environ Microbiol 1987; 53:1412-1417.

16. Carbonell LF, Miller LK. Genetic engineering of viral pesticides: Expression of foreign genes in nonpermissive cells. In: Arntzen CJ, Ryan C, Eds. Molecular Strategies for Crop Protection. UCLA Symposia on Molecular and Cellular Biology 48. New York: Alan R. Liss, Inc., 1987:235-242.

17. Sandig V, Hofmann C, Steinert S, Jennings G, Schlag P, Strauss M. Gene transfer into hepatocytes and human liver tissue by baculovirus vectors. Hum Gene Ther 1996; 7: 1937-1945.

18. Lehtolainen P, Tyynela K, Kannasto J, Airenne KJ, Yla-Hert-tuala S. Baculoviruses exhibit restricted cell type specificity in rat brain: A comparison of baculovirus- and adenovirus-mediated intracerebral gene transfer in vivo. Gene Ther 2002; 9:1693-1699.

19. Haeseleer F, Imanishi Y, Saperstein DA, Palczewski K. Gene transfer mediated by recombinant baculovirus into mouse eye. Invest Ophthalmol Vis Sci 2001; 42:3294-3300.

20. Sarkis C, Serguera C, Petres S, Buchet D, Ridet JL, Edelman L, Mallet J. Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector. Proc Natl Acad Sci USA 2000; 97:14638-14643.

21. Groner A. Specificity and safety of baculoviruses. In: Granados RR, Federici BA, Eds. The Biology of Bradioviruses, Vol. 4. Boca Raton: CRC Press, 1986:177-202.

22. Martignoni ME, Iwai PJ. A Catalog of Viral Diseases of Insects, Mites and Ticks. Portland. OR: U.S. Department of Agriculture, Forest Service, Pacific Northwest Research Station, 1986.

23. Summers MD, Anderson DL. Granulosis virus deoxyribonucleic acid: A closed, double-stranded molecule. J Virol 1972; 9:710-713.

24. Burgess S. Molecular weights of lepidopteran baculoviruses DNAs: Derivation by electron microscopy. J Gen Virol 1977; 37:501-510.

25. Tweeten KA, Bulla LA, Consigli RA. Characterization of an extremely basic protein derived from granulosis virus nucleo-capsid. J Virol 1980; 33:866-876.

26. Harrap KA. The structure of nuclear polyhedrosis viruses. II. The virus particle. Virology 1972; 50:124-132.

27. Williams GV, Faulkner P. Cytological changes and viral morphogenesis during baculovirus infection. In: Miller LK, Ed. The Baculoviruses. New York: Plenum Press, 1997:64-65.

28. van Loo ND, Fortunati E, Ehlert E, Rabelink M, Grosveld F, Scholte BJ. Baculovirus infection of nondividing mammalian cells: Mechanisms of entry and nuclear transport of capsids. J Virol 2001; 75:961-970.

29. Fraser MJ. Ultrastructural observations of virion maturation in Autographa californica nuclear polyhedrosis virus infected spodoptera frugiperda cell cultures. J Ultrastruct Mol Struct Res 1986; 95:189-195.

30. Miller LK. Baculoviruses as gene expression vectors. Annu Rev Microbiol 1988; 42:177-199.

31. Blissard GW. Baculovirus—insect cell interactions. Cytotech-nology 1996; 20:73-93.

32. Rohrmann GF. Baculovirus structural proteins. J Gen Virol 1992; 73:749-761.

33. Braunagel SC, Summers MD. Autographa californica nuclear polyhedrosis virus, PDV, and ECV viral envelopes and nucleo-capsids: Structural proteins, antigens, lipid and fatty acid profiles. Virology 1994; 202:315-328.

34. Wang P, Hammer DA, Granados RR. Binding and fusion of Autographa californica nucleopolyhedrovirus to cultured insect cells. J Gen Virol 1997; 78:3081-3089.

35. Granados RR. Early events in the infection of Hiliothis zea midgut cells by a baculovirus. Virology 1978; 90:170-174.

36. Summers MD. Electron microscopic observations on granulosis virus entry, uncoating and replication processes during infection of the midgut cells of Trichoplusia ni. J Ultrastruct Res 1971; 35:606-625.

37. Harrap KA. The structure of nuclear polyhedrosis viruses. I. The inclusion body. Virology 1972; 50:114-123.

38. Granados RR, Federici BA. The Biology of Baculoviruses. Boca Raton: CRC Press, 1986.

39. Harrap KA, Long worth JF. An evaluation of purification methods for baculoviruses. J Invertebr Pathol 1974; 24:55-62.

40. Granados RR, Williams KA. In vivo infection and replication of baculoviruses. In: Granados RR, Federici BA, Eds. The Biology of Baculoviruses. Boca Raton: CRC Press, 1986: 89-108.

41. Keddie BA, Aponte GW, Volkman LE. The pathway of infection of Autographa californica nuclear polyhedrosis virus in an insect host. Science 1989; 243:1728-1730.

42. Federici BA. Baculovirus pathogenesis. in: Miller LK, Ed. The Baculoviruses. New York: Plenum Press, 1997:33-59.

43. Chisholm GE, Henner DJ. Multiple early transcripts and splicing of the Autographa californica nuclear polyhedrosis virus IE-1 gene. J Virol 1988; 62:3193-3200.

44. Ayres MD, Howard SC, Kuzio J, Lopez-Ferber M, Possee RD. The complete DNA sequence of Autographa californica nuclear polyhedrosis virus. Virology 1994; 202:586-605.

45. Funk CJ, Braunagel SC, Rohrmann GF. Baculovirus structure. In: Miller LK, Ed. The Baculoviruses. New York: Plenum Press, 1997:7-32.

46. Braunagel SC, Summers MD. Autographa californica nuclear polyhedrosis virus, PDV, and ECV viral envelopes and nucleo-capsids: Structural proteins, antigens, lipid and fatty acid profiles. Virology 1994; 202:315-328.

47. Wilson ME, Consigli RA. Characterization of a protein kinase activity associated with purified capsids of the granulosis virus infection Plodia interpunctella. Virology 1985; 143:516-525.

48. Wilson ME, Consigli RA. Functions of a protein kinase activity associated with purified capsids of the granulosis virus infecting Plodia interpunctella. Virology 1985; 143:526-535.

49. Blissard GW, Wenz JR. Baculovirus gp64 envelope glycopro-tein is sufficient to mediate pH-dependent membrane fusion. J Virol 1992; 66:6829-6835.

50. Oomens AG, Blissard GW. Requirement for GP64 to drive efficient budding of Autographa californica multicapsid nucleopolyhedrovirus. Virology 1999; 254:297-314.

51. Duisit G, Saleun S, Douthe S, Barsoum J, Chadeuf G, Moullier P. Baculovirus vector requires electrostatic interactions including heparan sulfate for efficient gene transfer in mammalian cells. J Gene Med 1999; 1:93-102.

52. Tani H, Nishijima M, Ushijima H, Miyamura T, Matsuura Y. Characterization of cell-surface determinants important for baculovirus infection. Virology 2001; 279:343-353.

53. Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992; 69:11-25.

54. Vaughn JL, Goodwin RH, Tompkins GJ, McCawley P. The establishment of two cell lines from the insect Spodoptera frugiperda (Lepidoptera; Noctuidae). In Vitro 1977; 13: 213-217.

55. Wickham TJ, Davis T, Granados RR, Shuler ML, Wood HA. Screening of insect cell lines for the production of recombinant proteins and infectious virus in the baculovirus expression system. Biotechnol Prog 1992; 8:391-396.

56. Davis TR, Wickham TJ, McKenna KA, Granados RR, Shuler ML, Wood HA. Comparative recombinant protein production of eight insect cell lines. In Vitro Cell Dev Biol Anim 1993; 29A:388-390.

Wickham TJ, Nemerow GR, Wood HA, Shuler ML. Comparison of different cell lines for the production of recombinant baculovirus proteins. In: Richardson CD, Ed. Baculovirus expression protocols. Totowa: Humana Press, 1995:385-395. Smith GE, Fraser MJ, Summers MD. Molecular engineering of the Autographa californica nuclear polyhedrosis virus genome: Deletion mutations within the polyhedrin gene. J Virol 1983; 46:584-593.

Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M, Dong C, Weiner AJ, Lau JY, Choo QL, Chien D, Pileri P, Houghton M, Abrignani S. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorime-tric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci USA 1996; 93:1759-1763. Chazenbalk GD, Rapoport B. Expression of the extracellular domain of the thyrotropin receptor in the baculovirus system using a promoter active earlier than the polyhedrin promoter. Implications for the expression of functional highly glycosyl-ated proteins. J Biol Chem 1995; 270:1543-1549. Miller LK. Baculoviruses: High-level expression in insect cells. Curr Opin Genet Dev 1993; 3:97-101. Jarvis DL, Finn EE. Modifying the insect cell N-glycosylation pathway with immediate early baculovirus expression vectors. Nat Biotechnol 1996; 14:1288-1292.

Jones I, Morikawa Y. Baculovirus vectors for expression in insect cells. Curr Opin Biotechnol 1996; 7:512-516. Smith GE, Summers MD, Fraser MJ. Production of human beta interferon in insect cells with a baculovirus expression vector. Mol Cell Biol 1983; 3:2156-2165. Godeau F, Saucier C, Kourilsky P. Replication inhibition by nucleoside analogues of a recombinant Autographa californica multicapsid nuclear polyhedrosis virus harboring the herpes thymidine kinase gene driven by the IE-1(0) promoter: A new way to select recombinant baculoviruses. Nucleic Acids Res 1992; 20:6239-6246.

Davies AH. Current methods for manipulating baculoviruses. Biotechnology (NY) 1994; 12:47-50. Kitts PA, Ayres MD, Possee RD. Linearization of baculovirus DNA enhances the recovery of recombinant virus expression vectors. Nucleic Acids Res 1990; 18:5667-5672. Kitts PA, Possee RD. A method for producing recombinant baculovirus expression vectors at high frequency. Biotechniques 1993; 14:810-817.

Bishop DHL, Novy R, Mierendorf R. The BacVector system: Simplified cloning and protein expression unsing novel baculovirus vectors. Innovations 1995; 4:1-6. Je YH, Chang JH, Choi JH, Roh JY, Jin BR, O'Reilly DR, Kang SK. A defective viral genome maintained in Escherichia coli for the generation of baculovirus expression vectors. Bio-technol Lett 2001; 23:575-582.

Ernst WJ, Grabherr RM, Katinger HW. Direct cloning into the Autographa californica nuclear polyhedrosis virus for generation of recombinant baculoviruses. Nucleic Acids Res 1994; 22:2855-2856.

Peakman TC, Harris RA, Gewert DR. Highly efficient generation of recombinant baculoviruses by enzymatically medicated site-specific in vitro recombination. Nucleic Acids Res 1992; 20:495-500.

Patel G, Nasmyth K, Jones N. A new method for the isolation of recombinant baculovirus. Nucleic Acids Res 1332; 20: 97-104.

Luckow VA, Lee SC, Barry GF, Olins PO. Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. J Virol 1993; 67: 4566-4579.

75. Airenne KJ, Peltonaa E, Hytonen VP, Laitinen OH, Ylä-Hert-tuala S. Improved generation of recombinant baculovirus genomes in Escherichia coli. Nucleic Acids Res 2003; In press.

76. Mcintosh AH, Shamy R. Effects of the nuclear polyhedrosis virus (NPV) of Autographa californica on a vertebrate viper cell line. Ann NY Acad Sci 1975; 266:327-331.

77. Hofmann C, Wolfgang L, Strauss M. The baculovirus vector system for gene delivery into hepatocytes. Gene Ther Molec Biol 1998; 1:231-239.

78. Boyce FM, Bucher NL. Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 1996; 93: 2348-2352.

79. Gao R, McCormick CJ, Arthur MJ, Ruddell R, Oakley F, Smart DE, Murphy FR, Harris MP, Mann DA. High efficiency gene transfer into cultured primary rat and human hepatic stellate cells using baculovirus vectors. Liver 2002; 22:15-22.

80. Shoji I, Aizaki H, Tani H, Ishii K, Chiba T, Saito I, Miyamura T, Matsuura Y. Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J Gen Virol 1997; 78:2657-2664.

81. Yap CC, Ishii K, Aoki Y, Aizaki H, Tani H, Shimizu H, Ueno Y, Miyamura T, Matsuura Y. A hybrid baculovirus-T7 RNA polymerase system for recovery of an infectious virus from cDNA. Virology 1997; 231:192-200.

82. Barsoum J, Brown R, McKee M, Boyce FM. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum Gene Ther 1997; 8:2011-2018.

83. Zhu Y, QI Y, Liu Z, Xiao G. Baculovirus-mediated gene tranfer into mammalian cells. Sci China 1998; 41:473-478.

84. Condreay JP, Witherspoon SM, Clay WC, Kost TA. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci USA 1999; 96:127-132.

85. Palmiter RD, Sandgren EP, Avarbock MR, Allen DD, Brinster RL. Heterologous introns can enhance expression of transgenes in mice. Proc Natl Acad Sci USA 1991; 88: 478-482.

86. Lacy-Hulbert A, Thomas R, Li XP, Lilley CE, Coffin RS, Roes J. Interruption of coding sequences by heterologous introns can enhance the functional expression of recombinant genes. Gene Ther 2001; 8:649-653.

87. Donello JE, Loeb JE, Hope TJ. Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol 1998; 72:5085-5092.

88. De Geest B, Van Linthout S, Lox M, Collen D, Holvoet P. Sustained expression of human apolipoprotein A-I after adenoviral gene transfer in C57BL/6 mice: Role of apolipoprotein A-I promoter, apolipoprotein A-I introns, and human apolipo-protein E enhancer. Hum Gene Ther 2000; 11:101-112.

89. Ma L, Tamarina N, Wang Y, Kuznetsov A, Patel N, Kending C, Hering BJ, Philipson LH. Baculovirus-mediated gene transfer into pancreatic islet cells. Diabetes 2000; 49:1986-1991.

90. Aoki H, Sakoda Y, Jukuroki K, Takada A, Kida H, Fukusho A. Induction of antibodies in mice by a recombinant baculovirus expressing pseudorabies virus glycoprotein B in mammalian cells. Vet Microbiol 1999; 68:197-207.

91. Song SU, Boyce FM. Combination treatment for osteosarcoma with baculoviral vector mediated gene therapy (p53) and chemotherapy (adriamycin). Exp Mol Med 2001; 33:46-53.

92. Mastromarino P, Conti C, Goldoni P, Hauttecoeur B, Orsi N. Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH. J Gen Virol 1987; 68:2359-2369.

93. Eidelman O, Schlegel R, Tralka TS, Blumenthal R. pH-depen-dent fusion induced by vesicular stomatitis virus glycoprotein reconstituted into phospholipid vesicles. J Biol Chem 1984; 259:4622-4628.

94. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. In vivo gene delivery and stable transduction of nondividing cells by alentiviral vector. Science 1996; 272:263-267.

95. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK. Vesicular stomatitis virus G glycoprotein pseudotyped ret-roviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993; 90:8033-8037.

96. Poeschla EM, Wong-Staal F, Looney DJ. Efficient transduc-tion of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med 1998; 4:354-357.

97. Park SW, Lee HK, Kim TG, Yoon SK, Paik SY. Hepatocyte-specific gene expression by baculovirus pseudotyped with vesicular stomatitis virus envelope glycoprotein. Biochem Bio-phys Res Commun 2001; 289:444-450.

98. Pieroni L, Maione D, La Monica N. In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. Hum Gene Ther 2001; 12:871-881.

99. Mangor JT, Monsma SA, Johnson MC, Blissard GW. A GP64-null baculovirus pseudotyped with vesicular stomatitis virus G protein. J Virol 2001; 75:2544-2556.

100. Kruh J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem 1982; 42:65-82.

101. Yamano T, Ura K, Morishita R, Nakajima H, Monden M, Kaneda Y. Amplification of transgene expression in vitro and in vivo using a novel inhibitor of histone deacetylase. Mol Ther 2000; 1:574-580.

102. Berger SL. Gene regulation. Local or global?. Nature 2000; 408:412-413, 415.

103. Gaetano C, Catalano A, Palumbo R, Illi B, Orlando G, Ventor-uzzo G, Serino F, Capogrossi MC. Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo. Gene Ther 2000; 7:1624-1630.

104. Tobias CA, Kim D, Fischer I. Improved recombinant retroviral titers utilizing trichostatin A. Biotechniques 2000; 29: 884-890.

105. Fipaldini C, Bellei B, La Monica N. Expression of hepatitis C virus cDNA in human hepatoma cell line mediated by a hybrid baculovirus-HCV vector. Virology 1999; 255: 302-311.

106. Cheshenko N, Krougliak N, Eisensmith RC, Krougliak VA. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus. Gene Ther 2001; 8:846-854.

107. Palombo F, Monciotti A, Recchia A, Cortese R, Ciliberto G, La Monica N. Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector. J Virol 1998; 72:5025-5034.

108. Delaney WE, Isom HC. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant bacu-lovirus. Hepatology 1998; 28:1134-1146.

109. Delaney WE, Miller TG, Isom HC. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (— )-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA. Antimicrob Agents Chemother 1999; 43: 2017-2026.

110. Delaney WE, Edwards R, Colledge D, Shaw T, Torresi J, Miller TG, Isom HC, Bock CT, Manns MP, Trautwein C, Locarnini S. Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus. Antimicrob Agents Chemother 2001; 45:1705-1713.

111. Abdelhamed AM, Kelley CM, Miller TG, Furman PA, Isom HC. Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment. J Virol 2002; 76: 8148-8160.

112. McCormick CJ, Rowlands DJ, Harris M. Efficient delivery and regulable expression of hepatitis C virus full-length and minigenome constructs in hepatocyte-derived cell lines using baculovirus vectors. J Gen Virol 2002; 83:383-394.

113. Dwarakanath RS, Clark CL, McElroy AK, Spector DH. The use of recombinant baculoviruses for sustained expression of human cytomegalovirus immediate early proteins in fibro-blasts. Virology 2001; 284:297-307.

114. Saijo M, Niikura M, Morikawa S, Kurane I. Immunofluores-cence method for detection of Ebola virus immunoglobulin g, using HeLa cells which express recombinant nucleoprotein. J Clin Microbiol 2001; 39:776-778.

115. Bilello JP, Delaney WE, Boyce FM, Isom HC. Transient disruption of intercellular junctions enables baculovirus entry into nondividing hepatocytes. J Virol 2001; 75:9857-9871.

116. Granados RR, Lawler KA. In vivo pathway of Autographa californica baculovirus invasion and infection. Virology 1981; 108:297-308.

117. Kukkonen SP, Airenne KJ, Marjomäki V, Laitinen OH, Lehto-lainen P, Kankaanpaa P, Mahonen AJ, Raty JK, Nordlund HR, Oker-Blom C, Kulomaa MS, Yla-Herttuala S. Baculovirus capsid display: a novel tool for transduction imaging. 2003; in press.

118. Kircheis R, Wightman L, Schreiber A, Robitza B, Rossler V, Kursa M, Wagner E. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther 2001; 8:28-40.

119. Huser A, Rudolph M, Hofmann C. Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors. Nat Biotechnol 2001; 19:451-455.

120. Lindley KM, Su JL, Hodges PK, Wisely GB, Bledsoe RK, Condreay JP, Winegar DA, Hutchins JT, Kost TA. Production of monoclonal antibodies using recombinant baculovirus displaying gp64-fusion proteins. J Immunol Methods 2000; 234: 123-135.

121. Grabherr R, Ernst W, Oker-Blom C, Jones I. Developments in the use of baculoviruses for the surface display of complex eukaryotic proteins. Trends Biotechnol 2001; 19:231-236.

122. Tami C, Farber M, Palma EL, Taboga O. Presentation of anti-genic sites from foot-and-mouth disease virus on the surface of baculovirus and in the membrane of infected cells. Arch Virol 2000; 145:1815-1828.

123. LuW, Dong Z,DonawhoC, Fidler IJ. Specific immunotherapy against occult cancer metastases. Int J Cancer 2002; 100: 480-485.

124. Bae JE, Schurig GG, Toth TE. Mice immune responses to Brucella abortus heat shock proteins. Use of baculovirus re-combinant-expressing whole insect cells, purified Brucella abortus recombinant proteins, and a vaccinia virus recombinant as immunogens. Vet Microbiol 2002; 88:189-202.

125. Ignoffo CM, Heimpel AM. The nuclear-polyhedrosis virus of Heliothis zea (Boddie) and Heliothis virescens (Fabricus). V. Toxicity-pathogenicity of virus to white mice and guinea pigs. J Invert Pathol 1965; 7:329-340.

126. Miller LK. Introduction to the baculoviruses. In: Miller LK, Ed. The Baculoviruses. New York: Plenum Press, 1997:1-6.

127. Miller LK, Lu A. The molecular basis of baculovirus host range. In: Miller LK, Ed. The Baculoviruses. New York: Plenum Press, 1997:217-235.

128. Morel G, Fouillaud M. Presence of microorganisms and viral inclusion bodies in the nests of the paper wasp Polistes he-

braeus Fabiicus (Hymenoptera, Vespidae). J Invertebr Pathol 1992; 60:210.

Lautenschlager RA, Podgwaite JD. Passage rates of nucleopo-lyhedrosis virus by avian and mammalian predators of the gypsy moth. Environ Entomol 1979; 8:210. Entwistle PF, Adams PHW, Evans HF. Epizootiology of a nuclear polyhedrosis virus in European spruce sawly (Gilpinia hercyniae): The rate of passage of infective virus through the gut of birds during cage tests. J Invertebr Pathol 1978; 15:173. Groner A, Granados RR, Burand JP. Interaction of Autographa californica nuclear polyhedrosis virus with two nonpermissive cell lines. Intervirology 1984; 21:203-209. Boyce FM. Non-chemical gene transfer into mammalian cells. A new DNA transduction system based on baculovirus. Innovations 1999; 9:1-5.

Fallaux FJ, van der Eb AJ, Hoeben RC. Who's afraid of replication-competent adenoviruses?. Gene Ther 1996; 6:709-712. Marshall E. Clinical research. Gene therapy a suspect in leukemia-like disease. Science 2002; 298:34-35. Li Z, Dullmann J, Schiedlmeier B, Schmidt M, von Kalle C, Meyer J, Forster M, Stocking C, Wahlers A, Frank O, Ostertag W, Kuhlcke K, Eckert HG, Fehse B, Baum C. Murine leukemia induced by retroviral gene marking. Science 2002; 296: 497.

Pearson H. Liver tumours temper hopes for gene-therapy technique. Nature 2001; 413:9.

Donsante A, Vogler C, Muzyczka N, Crawford JM, Barker J, Flotte T, Campbell-Thompson M, Daly T, Sands MS. Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors. Gene Ther 2001; 8:1343-1346. Woods NB, Muessig A, Schmidt M, Flygare J, Olsson K, Salmon P, Trono D, von Kalle C, Karlsson S. Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: Risk of insertional mutagenesis. Blood 2003; 1018:1284-1289. Merrihew RV, Clay WC, Condreay JP, Witherspoon SM, Dallas WS, Kost TA. Chromosomal integration of transduced recombinant baculovirus DNA in mammalian cells. J Virol 2001; 75:903-909.

Tjia ST, zu Altenschildesche GM, Doerfler W. Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells. Virology 1983; 125:107-117.

Brusca J, Summers M, Couch J, Courtney L. Autographa cali-fornica nuclear polyhedrosis virus efficiently enters but does not replicate in poikilothermic vertebrate cells. Intervirology 1986; 26:207-222.

Halbert CL, Rutledge EA, Allen JM, Russell DW, Miller AD. Repeat transduction in the mouse lung by using adeno-associ-ated virus vectors with different serotypes. J Virol 2000; 74: 1524-1532.

Yang Y, Li Q, Ertl HC, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995; 69:2004-2015.

Krieg AM. Minding the Cs and Gs. Mol Ther 2000; 1: 209-210.

Ferguson TA, Griffith TS. A vision of cell death: Insights into immune privilege. Immunol Rev 1997; 156:167-184. Hofmann C, Strauss M. Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system. Gene Ther 1998; 5:531-536. Platt JL. Knocking out xenograft rejection. Nat Biotechnol 2002; 20:231-232.

Bianchet MA, Odom EW, Vasta GR, Amzel LM. A novel fucose recognition fold involved in innate immunity. Nat Struct Biol 2002; 9:628-634.

149. Kirschfink M. Targeting complement in therapy. Immunol Rev 2001; 180:177-189.

150. Barrington R, Zhang M, Fischer M, Carroll MC. The role of complement in inflammation and adaptive immunity. Immunol Rev 2001; 180:5-15.

151. Hofmann C, Huser A, Lehnert W, Strauss M. Protection of baculovirus-vectors against complement-mediated inactiva-tion by recombinant soluble complement receptor type 1. Biol Chem 1999; 380:393-395.

152. Beck NB, Sidhu JS, Omiecinski CJ. Baculovirus vectors repress phenobarbital-mediated gene induction and stimulate cy-tokine expression in primary cultures of rat hepatocytes. Gene Ther 2000; 7:1274-1283.

153. Gronowski AM, Hilbert DM, Sheehan KC, Garotta G, Schreiber RD. Baculovirus stimulates antiviral effects in mammalian cells. J Virol 1999; 73:9944-9951.

154. Hoopes RR, Rohrmann GF. In vitro transcription of baculovi-rus immediate early genes: Accurate mRNA initiation by nuclear extracts from both insect and human cells. Proc Natl Acad Sci USA 1991; 88:4513-4517.

155. Varga CM, Wickham TJ, Lauffenburger DA. Receptor-mediated targeting of gene delivery vectors: Insights from molecular mechanisms for improved vehicle design. Biotechnol Bioeng 2000; 70:593-605.

156. Krasnykh VN, Douglas JT, van Beusechem VW. Genetic targeting of adenoviral vectors. Mol Ther 2000; 1:391-405.

157. Peng KW. Strategies for targeting therapeutic gene delivery. Mol Med Today 1999; 5:448-453.

158. Barnett BG, Crews CJ, Douglas JT. Targeted adenoviral vectors. Biochim Biophys Acta 2002; 1575:1-14.

159. Walther W, Stein U. Cell type specific and inducible promoters for vectors in gene therapy as an approach for cell targeting. J Mol Med 1996; 74:379-392.

160. Nettelbeck DM, Jerome V, Muller R. Gene therapy: Designer promoters for tumour targeting. Trends Genet 2000; 16: 174-181.

161. Russell SJ, Cosset FL. Modifying the host range properties of retroviral vectors. J Gene Med 1999; 1:300-311.

162. Lavillette D, Russell SJ, Cosset FL. Retargeting gene delivery using surface-engineered retroviral vector particles. Curr Opin Biotechnol 2001; 12:461-466.

163. Ojala K, Mottershead DG, Suokko A, Oker-Blom C. Specific binding of baculoviruses displaying gp64 fusion proteins to mammalian cells. Biochem Biophys Res Commun 2001; 284: 777-784.

164. Glotzer JB, Michou AI, Baker A, Saltik M, Cotten M. Microtu-bule-independent motility and nuclear targeting of adenovir-uses with fluorescently labeled genomes. J Virol 2001; 75: 2421-2434.

165. Reimann R, Miltenburger HG. Cytogenetic studies in mammalian cells after treatment with insect pathogenic viruses [Bacu-loviridae]. II. In vitro studies with mammalian cell lines. Ento-maphaga 1983; 28:33-44.

166. Lung O, Westenberg M, Vlak JM, Zuidema D, Blissard GW. Pseudotyping Autographa californica multicapsid nucleopo-lyhedrovirus (AcMNPV): F proteins from group II NPVs are functionally analogous to AcMNPV GP64. J Virol 2002; 76: 5729-5736.

167. Yla-Herttuala S, Martin JF. Cardiovascular gene therapy. Lancet 2000; 355:213-222.

168. Van Craenenbroeck K, Vanhoenacker P, Haegeman G. Epi-somal vectors for gene expression in mammalian cells. Eur J Biochem 2000; 267:5665-5678.

169. Clackson T. Regulated gene expression systems. Gene Ther 174. 2000; 7:120-125.

170. Lewandoski M. Conditional control of gene expression in the mouse. Nat Rev Genet 2001; 2:743-755.

171. Sollerbrant K, Elmen J, Wahlestedt C, Acker J, Leblois-Pre- 175. haud H, Latta-Mahieu M, Yeh P, Perricaudet M. A novel method using baculovirus-mediated gene transfer for production of recombinant adeno-associated virus vectors. J Gen

Virol 2001; 82:2051-2060.

172. Boublik Y, Di Bonito P, Jones IM. Eukaryotic virus display: 176. Engineering the major surface glycoprotein of the Autographa californica nuclear polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus surface. Biotechnology (NY) 1995; 13:1079-1084. 177.

173. Grabherr R, Ernst W, Doblhoff-Dier O, Sara M, Katinger H. Expression of foreign proteins on the surface of Autographa californica nuclear polyhedrosis virus. Biotechniques 1997; 178. 22:730-735.

Mottershead D, dL van I, von Bonsdorff CH, Keinanen K, Oker-Blom C. Baculoviral display of the green fluorescent protein and rubella virus envelope proteins. Biochem Biophys Res Commun 1997; 238:717-722.

Russell RL, Pearson MN, Rohrmann GF. Immunoelectron microscopic examination of Orgyia pseudotsugata multicapsid nuclear polyhedrosis virus-infected Lymantria dispar cells: Time course and localization of major polyhedron-associated proteins. J Gen Virol 1991; 72:275-283. Georgi A, Mottola-Hartshorn C, Warner A, Fields B, Chen LB. Detection of individual fluorescently labeled reoviri-ons in living cells. Proc Natl Acad Sci USA 1990; 87: 6579-6583.

Ford KG, Souberbielle BE, Darling D, Farzaneh F. Protein transduction: An alternative to genetic intervention?. Gene Ther 2001; 8:1-4.

Matsuura Y. Efficient gene expression in mammalian cells by novel baculovirus vectors. RIKEN Rev 1999; 22:14-16.

0 0

Post a comment